NARI - Inari Medical, Inc.
IEX Last Trade
52.74
0.180 0.341%
Share volume: 16,535
Last Updated: Fri 27 Dec 2024 06:30:25 PM CET
Surgical and Medical Instrument Manufacturing :
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$52.56
0.18
0.34%
Fundamental analysis
12%
Profitability
2%
Dept financing
13%
Liquidity
59%
Performance
10%
Performance
5 Days
0.77%
1 Month
5.55%
3 Months
31.88%
6 Months
15.40%
1 Year
-16.55%
2 Year
-14.49%
Key data
Stock price
$52.74
DAY RANGE
$52.44 - $54.13
52 WEEK RANGE
$38.36 - $66.61
52 WEEK CHANGE
-$17.61
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/30/2024
Company detail
CEO: William H. Hoffman
Region: US
Website: inarimedical.com
Employees: 800
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: inarimedical.com
Employees: 800
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Inari Medical, Inc. develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels. FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.
Recent news